The crucial role of mast cells in blood-brain barrier alterations

Experimental Cell Research

Volumn 338, Issue 1, 2015, Pages 119-125

  Ribatti, Domenico ^a,b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Blood brain barrier; Brain; Mast cells; Neurodegenerative diseases

Indexed keywords

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; HUMAN; MAST CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; ANIMAL; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN NEOPLASMS; CEREBRAL HEMORRHAGE; HUMANS; MAST CELLS; MULTIPLE SCLEROSIS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84942198757     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.05.013     Document Type: Review

References (64)

1. Reese T.S., Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 1967, 34:207-217.
2. Wolburg H., Neuhaus J., Kniesel U., Krauss B., Schmid E.M., Ocalan M., Farrell C., Risau W. Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J. Cell Sci. 1994, 107(Pt 5):1347-1357.
3. Risau W., Dingler A., Albrecht U., Dehouck M.P., Cecchelli R. Blood-brain barrier pericytes are the main source of gamma-glutamyltranspeptidase activity in brain capillaries. J. Neurochem. 1992, 58:667-672.
4. Daneman R., Zhou L., Kebede A.A., Barres B.A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010, 468:562-566.
5. Armulik A., Genove G., Mae M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., Johansson B.R., Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
6. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.
7. Crivellato E., Ribatti D. The mast cell: an evolutionary perspective. Biol. Rev. Camb. Philos. Soc. 2010, 85:347-360.
8. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as tunable effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 2005, 23:749-786.
9. Johnson D., Krenger W. Interactions of mast cells with the nervous system-recent advances. Neurochem. Res. 1992, 17:939-951.
10. Dropp J.J. Mast cells in the human brain. Acta Anat. 1979, 105:505-513.
11. Crivellato E., Damiani D., Mallardi F., Travan L. Suggestive evidence for a microanatomical relationship between mast cells and nerve fibres containing substance P, calcitonin gene related peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery. Acta Anat. 1991, 141:127-131.
12. Stead R.H., Dixon M.F., Bramwell N.H., Riddell R.H., Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989, 97:575-585.
13. Stead R.H., Tomioka M., Quinonez G., Simon G.T., Felten S.Y., Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. USA 1987, 84:2975-2979.
14. Kim D.Y., Hong G.U., Ro J.Y. Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J. Neuroinflamm. 2011, 8. 25-25.
15. Kim D.Y., Jeoung D., Ro J.Y. Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J. Immunol. 2010, 185:273-283.
16. Hosli L., Hosli E., Schneider U., Wiget W. Evidence for the existence of histamine H1- and H2-receptors on astrocytes of cultured rat central nervous system. Neurosci. Lett. 1984, 48:287-291.
17. Dong Y., Benveniste E.N. Immune function of astrocytes. Glia 2001, 36:180-190.
18. Bulanova E., Bulfone-Paus S. P2 receptor-mediated signaling in mast cell biology. Purinergic Signal. 2010, 6:3-17.
19. Hudson C.A., Christophi G.P., Gruber R.C., Wilmore J.R., Lawrence D.A., Massa P.T. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 2008, 84:631-643.
20. Theoharides T.C., Donelan J., Kandere-Grzybowska K., Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res. Brain Res. Rev. 2005, 49:65-76.
21. Brenner T., Soffer D., Shalit M., Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 1994, 122:210-213.
22. Dietsch G.N., Hinrichs D.J. Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell Immunol. 1991, 135:541-548.
23. Johnson D., Seeldrayers P.A., Weiner H.L. The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 1988, 444:195-198.
24. Lindsberg P.J., Strbian D., Karjalainen-Lindsberg M.-L. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J. Cereb. Blood Flow Metab. 2010, 30:689-702.
25. Strbian D., Kovanen P.T., Karjalainen-Lindsberg M.L., Tatlisumak T., Lindsberg P.J. An emerging role of mast cells in cerebral ischemia and hemorrhage. Ann. Med. 2009, 41:438-450.
26. Marinkovic I., Mattila O.S., Strbian D., Meretoja A., Shekhar S., Saksi J., Abo-Ramadan U., Rantanen V., Lindsberg P.J., Tatlisumak T. Evolution of intracerebral hemorrhage after intravenous tPA: reversal of harmful effects with mast cell stabilization. J. Cereb. Blood Flow Metab. 2014, 34:176-181.
27. Lozada A., Maegele M., Stark H., Neugebauer E.M.A., Panula P. Traumatic brain injury results in mast cell increase and changes in regulation of central histamine receptors. Neuropathol. Appl. Neurobiol. 2005, 31:150-162.
28. Mattila O.S., Strbian D., Saksi J., Pikkarainen T.O., Rantanen V., Tatlisumak T., Lindsberg P.J. Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke 2011, 42:3600-3605.
29. Strbian D., Tatlisumak T., Ramadan U.A., Lindsberg P.J. Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 2007, 27:795-802.
30. Strbian D., Karjalainen-Lindsberg M.-L., Tatlisumak T., Lindsberg P.J. Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J. Cereb. Blood Flow Metab. 2006, 26:605-612.
31. Neuman J. Ueber das Vorkommen der sogneannten Mastzellen bei pathologischen Veraenderungen des Gehirns. Virchows Arch. Pathol. Anat. Physiol. 1890, 122:378-381.
32. Bomprezzi R., Ringner M., Kim S., Bittner M.L., Khan J., Chen Y., Elkahloun A., Yu A., Bielekova B., Meltzer P.S., Martin R., McFarland H.F., Trent J.M. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 2003, 12:2191-2199.
33. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
34. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 1995, 37:63-66.
35. Malamud V., Vaaknin A., Abramsky O., Mor M., Burgess L.E., Ben-Yehudah A., Lorberboum-Galski H. Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis. J. Neuroimmunol. 2003, 138:115-122.
36. Bunnett N.W. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin. Thromb. Hemost. 2006, 32(Suppl 1):S39-S48.
37. Steinman L., Zamvil S.S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 2005, 26:565-571.
38. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
39. Sayed B.A., Christy A.L., Walker M.E., Brown M.A. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?. J. Immunol. 2010, 184:6891-6900.
40. Secor V.H., Secor W.E., Gutekunst C.A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 2000, 191:813-822.
41. Gregory G.D., Raju S.S., Winandy S., Brown M.A. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J. Clin. Investig. 2006, 116:1327-1336.
42. Kempuraj D., Tagen M., Iliopoulou B.P., Clemons A., Vasiadi M., Boucher W., House M., Wolfberg A., Theoharides T.C. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells. Br. J. Pharmacol. 2008, 155:1076-1084.
43. Gregory G.D., Robbie-Ryan M., Secor V.H., Sabatino J.J., Brown M.A. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 2005, 35:3478-3486.
44. Rouleau A., Dimitriadou V., Trung Tuong M.D., Newlands G.F., Miller H.R., Schwartz J.C., Garbarg M. Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis. J. Neural. Transm. 1997, 104:399-417.
45. Sayed B.A., Christy A., Quirion M.R., Brown M.A. The master switch: the role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 2008, 26:705-739.
46. Tanzola M.B., Robbie-Ryan M., Gutekunst C.A., Brown M.A. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 2003, 171:4385-4391.
47. Sayed B.A., Walker M.E., Brown M.A. Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. J. Immunol. 2011, 186:3294-3298.
48. Rodewald H.R., Feyerabend T.B. Widesperad immunological functions of mast cells: fact or fiction?. Immunity 2012, 37:13-24.
49. Brown M.A., Hatfield J.K. Mast cells are important modifiers of autoimmune disease: with so much evidence, why is there still controversy?. Front. Immunol. 2012, 3:147.
50. Dimitriadou V., Pang X., Theoharides T.C. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int. J. Immunopharmacol. 2000, 22:673-684.
51. Dietsch G.N., Hinrichs D.J. The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 1989, 142:1476-1481.
52. Theoharides T.C., Rozniecki J.J., Sahagian G., Jocobson S., Kempuraj D., Conti P., Kalogeromitros D. Impact of stress and mast cells on brain metastases. J. Neuroimmunol. 2008, 205:1-7.
53. Polajeva J., Sjosten A.M., Lager N., Kastemar M., Waern I., Alafuzoff I., Smits A., Westermark B., Pejler G., Uhrbom L., Tchougounova E. Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS One 2011, 6:e25222.
54. Maslinska D., Wozniak R., Kaliszek A., Schmidt-Sidor B., Lipska A., Woolley D.E. Phenotype of mast cells in the brain tumor. Capillary hemangioblastoma, Folia neuropathologica/Association of Polish Neuropathologists and Medical Research Centre. Pol. Acad. Sci. 1999, 37:138-142.
55. Ho K.L. Ultrastructure of cerebellar capillary hemangioblastoma. II. Mast cells and angiogenesis. Acta Neuropathol. 1984, 64:308-318.
56. Reszec J., Hermanowicz A., Rutkowski R., Bernaczyk P., Mariak Z., Chyczewski L. Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema. J. Neurooncol. 2013, 115:119-125.
57. Greenberg D.A., Jin K. From angiogenesis to neuropathology. Nature 2005, 438:954-959.
58. Holley J.E., Newcombe J., Whatmore J.L., Gutowski N.J. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci. Lett. 2010, 470:65-70.
59. Proescholdt M.A., Jacobson S., Tresser N., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 2002, 61:914-925.
60. Graumann U., Reynolds R., Steck A.J., Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 2003, 13:554-573.
61. Tham E., Gielen A.W., Khademi M., Martin C., Piehl F. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand. J. Immunol. 2006, 64:609-622.
62. Ribatti D., Iaffaldano P., Marinaccio C., Trojano M. First evidence of in vivo pro-angiogenic activity of cerebrospinal fluid samples from multiple sclerosis patients. Clin. Exp. Med. 2014, [Epub ahead of print].
63. Ribatti D., Crivellato E. Mast Cells and Tumours: From Biology to Clinic 2011, Springer Science & Business Media, Dordrecht.
64. Ribatti D., Ranieri G. Tryptase, a novel angiogenic factor stored in mast cell granules. Exp. Cell Res. 2015, 332:157-162.